Group One Trading, L.P. Fulcrum Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $2.81 Billion
- Q3 2025
A detailed history of Group One Trading, L.P. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 5,760 shares of FULC stock, worth $49,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,760
Previous 5,619
2.51%
Holding current value
$49,939
Previous $38,000
31.58%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding FULC
# of Institutions
134Shares Held
55.4MCall Options Held
176KPut Options Held
13.5K-
Ra Capital Management, L.P. Boston, MA10.2MShares$88.7 Million1.53% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.38MShares$46.7 Million1.41% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$45.5 Million5.13% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$41.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.67MShares$40.5 Million1.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $451M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...